Back
Structure Therapeutics, Inc. Stock Price Chart
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Buy
77
GPCR
Structure Therapeutics, Inc.
Last Price:
$90.53
Seasonality Move:
-15.01%
7 Day Trial
ALL ACCESS PASS
$
7
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight selling pressure.
Structure Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.24 | Buy |
| 20-day SMA: | 74.35 | Buy |
| 50-day SMA: | 56.66 | Buy |
| 200-day SMA: | 31.06 | Buy |
| 8-day EMA: | 85.78 | Buy |
| 20-day EMA: | 76.04 | Buy |
| 50-day EMA: | 61.08 | Buy |
| 200-day EMA: | 38.56 | Buy |
Structure Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.62 | Buy |
| Relative Strength Index (14 RSI): | 77.47 | Buy |
| Chaikin Money Flow: | -244323 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Structure Therapeutics, Inc. Technical Analysis
| Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics, Inc. Stock
Is Structure Therapeutics, Inc. Stock a Buy?
-
Structure Therapeutics, Inc. share price is 91.87 while GPCR 8-day simple moving average is 85.24, which is a Buy signal.
-
The stock price of GPCR is 91.87 while Structure Therapeutics, Inc. 20-day SMA is 74.35, which makes it a Buy.
-
Structure Therapeutics, Inc. 50-day simple moving average is 56.66 while GPCR share price is 91.87, making it a Buy technically.
-
GPCR stock price is 91.87 and Structure Therapeutics, Inc. 200-day simple moving average is 31.06, creating a Buy signal.
GPCR Technical Analysis vs Fundamental Analysis
Buy
77
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy or a Sell?
-
Structure Therapeutics, Inc. stock is rated a BuyThe current Structure Therapeutics, Inc. [GPCR] share price is $91.87. The Score for GPCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
Structure Therapeutics, Inc. Stock Info
Market Cap:
5.2B
Price in USD:
91.87
Share Volume:
1.2M
Structure Therapeutics, Inc. 52-Week Range
52-Week High:
94.90
52-Week Low:
13.22
Buy
77
Structure Therapeutics, Inc. (GPCR)
is a Buy
Structure Therapeutics, Inc. Share Price Forecast
-
What is the Structure Therapeutics, Inc. stock price today?The Structure Therapeutics, Inc. stock price is 91.87 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics, Inc. is not overvalued.
Is Structure Therapeutics, Inc. Stock a Buy?
-
Structure Therapeutics, Inc. share price is 91.87 while GPCR 8-day exponential moving average is 85.78, which is a Buy signal.
-
The stock price of GPCR is 91.87 while Structure Therapeutics, Inc. 20-day EMA is 76.04, which makes it a Buy.
-
Structure Therapeutics, Inc. 50-day exponential moving average is 61.08 while GPCR share price is 91.87, making it a Buy technically.
-
GPCR stock price is 91.87 and Structure Therapeutics, Inc. 200-day simple moving average is 38.56, creating a Buy signal.
Fundamental Analysis of Structure Therapeutics, Inc.
Is Structure Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.34 per share.
Technical Analysis of Structure Therapeutics, Inc.
Should I short Structure Therapeutics, Inc. stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is 9.62, suggesting Structure Therapeutics, Inc. is a Buy
-
Structure Therapeutics, Inc. Relative Strength Index (RSI) is 77.47, which suggest Structure Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Structure Therapeutics, Inc. is ( - ), which suggest Structure Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Structure Therapeutics, Inc. is ( - ), which suggest Structure Therapeutics, Inc. is a Buy
* Structure Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.